The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Research Funding - Array BioPharma; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
A phase II study of autologous tumor infiltrating lymphocytes (TIL, LN-144/LN-145) in patients with solid tumors.
 
Jason Alan Chesney
Consulting or Advisory Role - Amgen; Replimune
Research Funding - Amgen; Bristol-Myers Squibb; Iovance Biotherapeutics; MedImmune; MedImmune; Replimune
Patents, Royalties, Other Intellectual Property - University of Louisville US Patents
Travel, Accommodations, Expenses - Amgen; Replimune
 
Jose Lutzky
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Novartis
Speakers' Bureau - Array BioPharma; Novartis; Regeneron
Research Funding - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Elios Pharmaceutical; Genentech/Roche; Incyte; Merck; Merck Serono; Novartis; Pfizer; Viralytics
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer
 
Sajeve Samuel Thomas
Honoraria - Amgen; Array BioPharma; Bristol-Myers Squibb; Genentech; Ipsen; Merck; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Merck
Speakers' Bureau - Amgen; Array BioPharma; Bristol-Myers Squibb; Genentech; Ipsen; Merck; Novartis
Research Funding - Bristol-Myers Squibb; Genentech; Idera; Iovance Biotherapeutics; Merck; PISA Pharmaceutical
Travel, Accommodations, Expenses - Amgen; Array BioPharma; Bristol-Myers Squibb; Genentech; Ipsen; Merck; Novartis
 
Jorge J. Nieva
Stock and Other Ownership Interests - Epic Sciences
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Western Oncolytics
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - Patent Pending - movement and unexpected healthcare encounters
 
Eva Munoz Couselo
No Relationships to Disclose
 
Juan Martin-Liberal
Consulting or Advisory Role - Novartis; Roche
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; MSD; Novartis; Pfizer; Pierre Fabre; Roche
 
Juan Francisco Rodriguez-Moreno
Consulting or Advisory Role - Amgen; BioClin Therapeutics; Bristol-Myers Squibb; Novartis
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer; Roche
Research Funding - Abbvie; Amgen; Aprea AB; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
 
Alex Cacovean
Employment - Iovance Biotherapeutics; Pharmacyclics
Stock and Other Ownership Interests - Abbvie; Iovance Biotherapeutics
 
Huiling Li
Employment - Iovance Biotherapeutics
Stock and Other Ownership Interests - Iovance Biotherapeutics
 
Maria Fardis
Employment - Acerta Pharma; Iovance Biotherapeutics
Leadership - Acerta Pharma; Iovance Biotherapeutics
Stock and Other Ownership Interests - Abbvie; Acerta Pharma; Gilead Sciences; Iovance Biotherapeutics
Patents, Royalties, Other Intellectual Property - Acerta Pharma (Inst); Iovance Biotherapeutics (Inst)
Travel, Accommodations, Expenses - Acerta Pharma; Iovance Biotherapeutics
 
Scott N. Gettinger
Consulting or Advisory Role - Bristol-Myers Squibb; NEKTAR
Research Funding - ARIAD/Takeda (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Iovance Biotherapeutics (Inst)